Trump announces 150 million Abbott COVID-19 tests will be deployed across the US
September 29, 2020Manufacturing and Production
President Donald Trump announced on Monday that the government will distribute 150 million coronavirus tests from Abbott Laboratories across the …
FDA pauses the planning stages of Inovio’s late-stage COVID-19 vaccine trials
September 29, 2020Manufacturing and Production COVID-19 vaccine, FDA, coronavirus vaccines
The FDA has put Inovio’s planning stages for the final trials of its coronavirus vaccine on hold as the regulator …
Jyseleca secures European approval in rheumatoid arthritis
September 28, 2020Research and Development, Sales and Marketing Europe, Jyseleca, arthritis, pharma
The European Commission has awarded approval to Gilead and Galpagos for their oral JAK inhibitor Jyseleca (filgotinib) as a treatment …
Novel prophylactic nasal spray reduced COVID-19 replication by 96% in animal studies
September 28, 2020Research and Development, Sales and Marketing COVID-19, Ena Respiratory, Nasal Spray
Australian biotech Ena Respiratory has revealed new data demonstrating that its novel nasal spray almost halted replication of the SARS-CoV-2 …
FDA approves GlaxoSmithKline’s Nucala to treat hypereosinophilic syndrome
September 28, 2020Sales and Marketing
The FDA has announced its approval of GlaxoSmithKline’s Nucala (mepolizumab) as a treatment for hypereosinophilic syndrome (HES). This is specifically …
UK promises £500m to global vaccine sharing scheme
September 28, 2020Sales and Marketing
UK Prime Minister Boris Johnson has announced in a speech to the UN General Assembly that the UK is set …
FDA issues a warning against Benadryl TikTok challenge
September 28, 2020Medical Communications, Sales and Marketing Benadryl, FDA, TikTok
The FDA has released a warning following cases of teens filming themselves overdosing on the antihistamine Benadryl and uploading the …
Japan approves Gilead and Eisai’s Jyseleca for rheumatoid arthritis
September 25, 2020Medical Communications, Sales and Marketing Eisai, Gilead, Japan, Jyseleca
Gilead and Eisai have secured approval for their oral JAK1 preferential inhibitor Jyseleca (filgotinib) from the Japanese Ministry of Health, …
GSK confirms deal to supply 300 million COVID-19 vaccine doses to the EU
September 25, 2020Manufacturing and Production, Medical Communications COVID-19, EU, GSK, Vaccine
GlaxoSmithKline has confirmed a new COVID-19 vaccine supply deal to deliver 300 million doses of its candidate to the European …
Trump approves plan to make the import of Canadian drugs easier
September 25, 2020Medical Communications
President Trump has outlined his “America First Health Plan” on Thursday, which will allow the easy importation of prescription drugs …
British consumers have increasingly turned to community pharmacies during COVID-19
September 25, 2020Medical Communications
British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. Research conducted by …
Top Ten most popular articles on Pharmafile.com this week
September 25, 2020Medical Communications
The top 10 news stories this week focus on coronavirus vaccine trials, as around one in seven patients who have …
Novartis’ Zolgensma hits regulatory hurdle after FDA asks to review another study
September 24, 2020Research and Development FDA
The FDA has requested an additional study in older children being treated with Novartis’ Zolgensma in the review process for …
COVID-19 track and trace app launched in England and Wales after months of delays
September 24, 2020Medical Communications, Sales and Marketing UK, VOCID-19, app, test and trace
The UK Government’s track and trace app for COVID-19 has finally launched in England and Wales, after months of delays …
FDA grants Emergency Use Authorization for first antibody point-of-care COVID-19 test
September 24, 2020Research and Development
The FDA has issued an Emergency Use Authorization (EUA) for the first antibody (serology) point-of-care test for coronavirus. This is …
‘Smart drugs’ may contain unapproved pharmaceuticals, according to a new study
September 24, 2020Sales and Marketing FDA, regulation, smart drugs
Some supplements billed as ‘smart drugs’ may contain unapproved drugs in potentially dangerous combinations and doses, according to a new …
Gilead agrees to pay $97 million to settle Medicare kickbacks case
September 24, 2020Business Services Gilead, Medicare, drugs, kickbacks
Gilead has agreed to pay $97 million to resolve claims from the US Government that it used an independent charity …
Science community calls for transparency on AstraZeneca’s halted US COVID-19 vaccine trial
September 23, 2020Research and Development AstraZeneca, COVID-19, Vaccine
The halting of AstraZeneca’s COVID-19 vaccine trial around the world was cause for much initial concern over the eventual safety …
Fujifilm’s Avigan reduces recovery time in non-severe COVID-19 patients
September 23, 2020Research and Development, Sales and Marketing
Fujifilm has announced promising new Phase 3 findings demonstrating that its antiviral therapy Avigan (favipravir) had a statistically significant impact …
FDA set to announce stricter criteria for COVID-19 vaccines to receive Emergency Use Authorization
September 23, 2020Research and Development
The FDA is set to release new guidelines that would raise safety and efficacy requirements required for a COVID-19 vaccine …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
